HWP
LLY icon

Highline Wealth Partners’s Eli Lilly LLY Stock Holding History

Highline Wealth Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216K Buy
180
+31
+21% +$31.7K 0.04% 106
2026
Q1 		$137K Buy
149
+17
+13% +$17.2K 0.04% 103
2025
Q4 		$142K Buy
132
+15
+13% +$14.3K 0.04% 79
2025
Q3 		$89.4K Buy
117
+43
+58% +$32K 0.02% 125
2025
Q2 		$57.8K Buy
74
+5
+7% +$3.88K 0.02% 142
2025
Q1 		$57.1K Buy
69
+24
+53% +$20K 0.02% 127
2024
Q4 		$34.8K Buy
45
+20
+80% +$16.6K 0.01% 150
2024
Q3 		$22.2K Sell
25
-6
-19% -$5.39K 0.01% 181
2024
Q2 		$28.1K Buy
31
+16
+107% +$12.8K 0.01% 154
2024
Q1 		$11.7K Hold
15
– – ﹤0.01% 216
2023
Q4 		$8.74K Hold
15
– – ﹤0.01% 213
2023
Q3 		$8.06K Hold
15
– – 0.01% 202
2023
Q2 		$7.04K Hold
15
– – ﹤0.01% 170
2023
Q1 		$5.15K Hold
15
– – ﹤0.01% 178
2022
Q4 		$5.49K Hold
15
– – ﹤0.01% 173
2022
Q3 		$4.85K Buy
+15
New +$4.75K ﹤0.01% 164

Other funds holding LLY

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Highline Wealth Partners's LLY Position: Q2 2026 in Review

Highline Wealth Partners increased its Eli Lilly (LLY) stake by 21% in Q2 2026, buying an estimated $31.7K and bringing the position to 180 shares worth $216K. The position accounts for 0.04% of the portfolio, ranked #106.

Highline Wealth Partners first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Highline Wealth Partners held 180 shares of Eli Lilly worth $216K as of Q2 2026.
  • Highline Wealth Partners bought 31 Eli Lilly shares in Q2 2026, an estimated $31.7K.
  • Eli Lilly made up 0.04% of Highline Wealth Partners's portfolio in Q2 2026, its #106 holding.
  • Highline Wealth Partners first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.